Jiangsu HengRui Medicine Co., Ltd.

NCT07241767

Phase 2Recruiting2025200 people21 Nov 2025clinicaltrials.gov

NCT07073157

Phase 1Completed202524 people18 Jul 2025clinicaltrials.gov

NCT06881264

Phase 3Completed2024401 people18 Mar 2025clinicaltrials.gov

NCT06871761

Phase 3Completed2024393 people12 Mar 2025clinicaltrials.gov

NCT06688123

Phase 2Completed2025275 people14 Nov 2024clinicaltrials.gov

NCT06430437

Phase 3Recruiting2024300 people28 May 2024clinicaltrials.gov

NCT05798793

CollaboratorPhase 3Status unknown2023309 people5 Apr 2023clinicaltrials.gov

NCT05702073

Phase 3Completed2023423 people27 Jan 2023clinicaltrials.gov

NCT05699408

Phase 3Completed2023513 people26 Jan 2023clinicaltrials.gov

NCT05463601

CollaboratorPhase 2Active, not recruiting2022132 people19 Jul 2022clinicaltrials.gov

NCT05392127

Phase 1Completed202224 people26 May 2022clinicaltrials.gov

NCT05273775

Phase 1Completed202222 people10 Mar 2022clinicaltrials.gov

NCT05189184

CollaboratorPhase 2Status unknown202230 people12 Jan 2022clinicaltrials.gov

NCT05088343

Phase 1Completed202014 people21 Oct 2021clinicaltrials.gov

NCT04826679

CollaboratorPhase 2Status unknown202153 people1 Apr 2021clinicaltrials.gov

NCT04718740

Phase 1Completed202133 people22 Jan 2021clinicaltrials.gov

NCT04676035

Phase 1Completed202018 people19 Dec 2020clinicaltrials.gov

NCT04667143

Phase 3Status unknown2021760 people14 Dec 2020clinicaltrials.gov

NCT04621669

Phase 1Completed202136 people9 Nov 2020clinicaltrials.gov

NCT04613674

Phase 3Completed2020441 people3 Nov 2020clinicaltrials.gov